Indicators

Fate Therapeutics (NQ: FATE )

3.170 +0.490 (+18.28%)

Streaming Delayed Price Updated: 4:00 PM EST, Nov 27, 2024 Add to My Watchlist

Insider Filings

< Previous 1 2 3 4 Next >

Form 4

Source: SEC/Edgar

May 03, 2018

Form 4

Source: SEC/Edgar

May 03, 2018

Form 4

Source: SEC/Edgar

May 03, 2018

Form 4

Source: SEC/Edgar

May 03, 2018

Form 4

Source: SEC/Edgar

May 03, 2018

Form 3

Source: SEC/Edgar

December 18, 2017

Form 4

Source: SEC/Edgar

October 16, 2017

Form 4

Source: SEC/Edgar

October 16, 2017

Form 4

Source: SEC/Edgar

October 16, 2017

Form 4

Source: SEC/Edgar

January 05, 2017

Form 4

Source: SEC/Edgar

January 05, 2017

Form 4

Source: SEC/Edgar

January 05, 2017

Form 4

Source: SEC/Edgar

January 05, 2017

Form 4

Source: SEC/Edgar

January 05, 2017

Form 4

Source: SEC/Edgar

November 27, 2016

Form 4

Source: SEC/Edgar

November 27, 2016

Form 4

Source: SEC/Edgar

November 27, 2016

Form 4

Source: SEC/Edgar

August 23, 2016

Form 3

Source: SEC/Edgar

May 17, 2016

Form 4

Source: SEC/Edgar

May 17, 2016

Form 4

Source: SEC/Edgar

May 12, 2016

Form 4

Source: SEC/Edgar

May 12, 2016

Form 4

Source: SEC/Edgar

May 12, 2016

Form 4

Source: SEC/Edgar

May 12, 2016

Form 4

Source: SEC/Edgar

May 12, 2016

Form 4

Source: SEC/Edgar

May 12, 2016

Form 4

Source: SEC/Edgar

January 19, 2016

Form 4

Source: SEC/Edgar

January 13, 2016

Form 4

Source: SEC/Edgar

January 11, 2016

Form 4

Source: SEC/Edgar

January 11, 2016

< Previous 1 2 3 4 Next >

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.